Les Meilleures Cliniques et Coûts des traitements de carcinomatose en Ukraine 2026

Ukraine treats carcinomatosis using a combination of cytoreductive surgery and intraperitoneal chemotherapy. Specialist centers in Kyiv and other cities perform R0/R1 resections. They aim to remove all visible tumor nodes. Surgeons then apply heated chemotherapy directly to the abdomen.

• Surgical approach: Specialists perform cytoreductive surgery to remove all macroscopic abdominal tumors.
• Specialized techniques: Hyperthermic Intraperitoneal Chemotherapy (HIPEC) delivers heated drugs to the peritoneal cavity.
• Aerosol delivery: Some centers utilize PIPAC to spray chemotherapy as a pressurized aerosol.
• Accreditation standards: Leading networks like Dobrobut maintain ISO standards for oncology and surgery.

Bookimed Expert Insight: Ukraine offers high surgical volume in private networks despite regional challenges. The Dobrobut Medical Network alone performs over 11,000 yearly operations across 18 departments. This concentration of cases helps surgical teams maintain high proficiency in complex debulking. Patients should look for centers with ISO certification to ensure standardized safety protocols.

Patient Consensus: Patients emphasize that finding a surgeon who specializes in peritoneal surface malignancy is vital. Many note that treatment goals often focus on extending lifespan and improving comfort when surgery is possible.

Patients ineligible for extensive cytoreductive surgery often utilize systemic chemotherapy or targeted therapy to control disease spread. Options include palliative debulking to relieve obstructions and local treatments like intraperitoneal chemotherapy. These approaches prioritize maintaining quality of life when full tumor removal remains high-risk.

• Systemic chemotherapy: Common baseline treatment targeting diffuse peritoneal disease and stabilizing tumor growth.
• Palliative debulking: Focuses on removing specific masses to alleviate pain or bowel obstructions.
• Targeted therapy: Employs specialized drugs based on specific genetic markers of the primary cancer.
• Regional therapy: Non-HIPEC intraperitoneal chemotherapy delivers medication directly into the abdomen for localized control.

Bookimed Expert Insight: Patient fitness often dictates surgical eligibility as much as tumor spread does. Prof. Dr. Rostyslav Valikhnovskyi at VALIKHNOVSKI Surgery Institute has performed over 15,000 procedures. His background in reconstructive and oncologic surgery highlights that high-volume specialists may offer alternative palliative maneuvers. Specialized Ukrainian centers like Dobrobut Medical Network treat over 330,000 patients annually. They use ISO-certified standards to manage complex oncology cases through multidisciplinary consultations.

Patient Consensus: Patients emphasize the need to clarify if a surgery's goal is curative or symptom relief. Many seek second opinions because surgical candidacy can vary based on a surgeon's specific experience level.

Kyiv, Lviv, and Odesa house Ukraine's leading centers for carcinomatosis treatment. These hubs feature specialized oncology institutes providing multidisciplinary care. Kyiv serves as the primary destination. It offers advanced surgical oncology and hyperthermic intraperitoneal chemotherapy (HIPEC) at facilities like the National Cancer Institute.

• Kyiv centers: National Cancer Institute and LISOD provide international protocol-based oncology care.
• Specialized techniques: Facilities offer cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
• Western hub: Lviv Oncology Regional Center serves as the leading facility in Western Ukraine.
• Network capacity: Dobrobut Medical Network in Kyiv performs over 11,000 operations annually.

Bookimed Expert Insight: Kyiv centers maintain the highest surgical volume in Ukraine for peritoneal malignancies. Dobrobut Medical Network alone handles over 330,000 patients every year across its branches. Data shows that high-volume centers in Kyiv typically offer more comprehensive multidisciplinary reviews. This coordination is vital for managing complex carcinomatosis cases effectively.

Patient Consensus: Patients emphasize traveling to Kyiv or Lviv to access experienced surgical teams. They note that verifying a surgeon's specific experience with peritoneal surface malignancy is more important than the clinic's general reputation.

Cancer treatment in Ukraine uses public funding through the National Health Service of Ukraine (NHSU). The Program of Medical Guarantees covers diagnostics, surgery, chemotherapy, and radiation. Patients often supplement this with out-of-pocket payments for specific medications, consumables, and private-sector services.

• Public funding: The NHSU covers essential oncology services at authorized state facilities.
• Private network: Networks like Dobrobut Medical Network provide oncology care in Kyiv.
• Advanced access: Managed access agreements will expand coverage for immunotherapy by June 2026.
• Out-of-pocket costs: Patients frequently pay for pathology, imaging, and specific chemotherapy drugs.

Bookimed Expert Insight: Ukraine ranks 3rd in our oncology requests, showing high demand for its 50+ specialized clinics. While public centers handle bulk volume, private facilities like Dobrobut serve over 330,000 patients annually. Choosing private care often bypasses the typical public system delays for diagnostics like histopathology revision.

Patient Consensus: Patients note that public funding covers basics but often requires community fundraising for supplements. They recommend getting an itemized treatment plan to budget for medication and transport gaps.